INmune Bio Inc.

8-K Other events Jul 31, 2026 8-K Entered a material agreement Jul 1, 2026 8-K Other events Jun 23, 2026 8-K Director or officer change; Shareholder vote results Jun 17, 2026 8-K Other events Jun 2, 2026 8-K Other events May 14, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Entered a material agreement; Regulation FD disclosure May 5, 2026 10-K Fiscal year ended 2025-12-31 Mar 30, 2026 8-K Regulation FD disclosure Feb 27, 2026 8-K Other events Feb 23, 2026 8-K Other events Feb 19, 2026 8-K Regulation FD disclosure Feb 13, 2026 8-K Regulation FD disclosure Jan 27, 2026 8-K Entered a material agreement Dec 23, 2025 8-K Entered a material agreement Dec 19, 2025 8-K Terminated a material agreement Dec 10, 2025 8-K Entered a material agreement; Modified rights of security holders Dec 8, 2025 8-K Other events Dec 5, 2025 8-K Director or officer change Dec 3, 2025 8-K Director or officer change Nov 28, 2025 8-K Director or officer change; Shareholder vote results; Other events Nov 18, 2025 8-K Regulation FD disclosure Nov 10, 2025 8-K Results of operations (earnings release) Oct 30, 2025 10-Q Quarter ended 2025-09-30 Oct 30, 2025 8-K Other events Oct 28, 2025 8-K Other events Oct 14, 2025 8-K Other events Sep 30, 2025 8-K Results of operations (earnings release); Other events Aug 7, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Other events Jul 29, 2025 8-K Other events Jul 25, 2025 8-K Entered a material agreement; Other events Jun 30, 2025 8-K Other events Jun 30, 2025 8-K Other events Jun 26, 2025 8-K Director or officer change; Shareholder vote results; Other events Jun 10, 2025 8-K Other events May 14, 2025 8-K Results of operations (earnings release) May 8, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Changed accountants May 7, 2025